临床试验/NCT01507454

NCT01507454已完成不适用

Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

Novo Nordisk A/S1 个研究点分布在 1 个国家目标入组 1,613 人开始时间: 2006年4月最近更新: 2017年2月8日

适应症

干预措施

试验速览

阶段: 不适用
状态: 已完成
发起方: Novo Nordisk A/S
入组人数: 1,613
试验地点: 1
主要终点: Percentage of subjects reporting vaginal symptoms occuring 'often' and 'frequently'

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

This study is conducted in Europe. The aim of this study is to investigate the self-reported impact of Vagifem® (estradiol) treatment on urogenital discomfort in women with atrophic vaginitis due to oestrogen deficiency.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

性别: Female
接受健康志愿者: 否

入选标准

•Atrophic vaginitis due to estrogen deficiency
•Post-menopausal

排除标准

未提供

研究组 & 干预措施

Local treatment

干预措施: estradiol, 25 mcg (Drug)

结局指标

主要结局

Percentage of subjects reporting vaginal symptoms occuring 'often' and 'frequently'

Percentage of subjects reporting 'moderate' and 'severe' vaginal symptoms

次要结局

Adverse events

研究者

发起方

Novo Nordisk A/S

申办方类型

Industry

责任方

Sponsor

研究点 (1)

Loading locations...

相似试验

已完成

不适用

Elastographic Improvement of Vaginal Atrophy Treated by Erbium Yag LaserVaginal AtrophyLaserDyspareuniaGenitourinary Syndrome of Menopause (GSM)

NCT06000202Istanbul University - Cerrahpasa20

已完成

不适用

Evaluation of VagiVital® for Treatment of Vaginal AtrophyVaginal Atrophy

NCT03998722PepTonic Medical AB31

终止

3 期

A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic VaginitisAtrophic Vaginitis

NCT00816556Maire Mac Bride63

已完成

不适用

Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and EfficacyFemale Sexual Dysfunction

NCT03479229Viveve Inc.250

已完成

不适用

Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROMVulvovaginal AtrophyGenitourinary Syndrome of MenopauseMenopause

NCT04746456Massachusetts General Hospital210